Physician profile
Sheetal Wagle
NPI 1508075276
$19,803.77
in general payments reported to CMS, 2019-2025
61 companies · $3,418 in 2025
The $3,418 reported for 2025 was more than what 80% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,224 · 2020: $1,674 · 2021: $2,835 · 2022: $3,298 · 2023: $3,166 · 2024: $3,189 · 2025: $3,418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,502 · Education: $270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,502.13 |
| Education | $269.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,281.75 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $2,196.70 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Abbvie INC. | $1,759.03 | 2021-2025 | Ubrelvy, Qulipta, Botox |
| Biogen, INC. | $1,025.59 | 2019-2025 | Vumerity, Tysabri, Tysabri |
| Neurocrine Biosciences, INC. | $826.32 | 2021-2025 | Ongentys, Ingrezza |
| Lilly USA, LLC | $816.15 | 2019-2025 | Emgality, Reyvow, Kisunla |
| Ucb, INC. | $777.21 | 2019-2025 | Zilbrysq, Rystiggo, Briviact |
| Emd Serono, INC. | $760.81 | 2019-2025 | Mavenclad |
| Allergan, INC. | $611.89 | 2019-2022 | |
| Eisai INC. | $573.64 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $504.91 | 2019-2025 | Ultomiris |
| Grifols USA, LLC | $499.21 | 2019-2025 | Gamunex-C |
| Sk Life Science, INC. | $469.10 | 2021-2025 | |
| Genentech USA, INC. | $465.71 | 2019-2025 | Ocrevus, Ocrevus Zunovo |
| Pfizer INC. | $464.81 | 2021-2025 |
Show all 61 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $436.69 | 2019-2025 | Hizentra |
| Celgene Corporation | $390.29 | 2020-2025 | Zeposia |
| Amgen INC. | $366.49 | 2019-2025 | Uplizna |
| Lundbeck LLC | $363.73 | 2023-2025 | Vyepti |
| Greenwich Biosciences, INC. | $335.12 | 2019-2021 | |
| Neurelis, INC. | $329.79 | 2020-2025 | Valtoco |
| Sunovion Pharmaceuticals INC. | $282.80 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $251.54 | 2022 | |
| Genzyme Corporation | $236.14 | 2019-2022 | |
| Argenx US, INC. | $224.00 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Biohaven Pharmaceuticals, INC. | $202.10 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $172.41 | 2024-2025 | Hyqvia |
| Janssen Biotech, INC. | $154.28 | 2025 | |
| Almatica Pharma LLC | $147.56 | 2021-2023 | Gralise |
| Scilex Pharmaceuticals INC. | $123.64 | 2023-2025 | Ztlido |
| Ge Healthcare | $115.79 | 2019-2023 | |
| Merz Pharmaceuticals, LLC | $102.84 | 2023-2025 | Xeomin |
| Acadia Pharmaceuticals INC | $101.11 | 2019-2025 | Nuplazid |
| Livanova USA, INC. | $100.81 | 2019-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Janssen Pharmaceuticals, INC | $100.41 | 2022-2023 | Ponvory |
| E.R. Squibb & Sons, L.L.C. | $93.14 | 2020-2021 | |
| Mdd US Operations, LLC | $91.79 | 2024 | Gocovri |
| Collegium Pharmaceutical, INC. | $88.49 | 2022 | |
| Arbor Pharmaceuticals, INC. | $83.41 | 2019-2022 | |
| Azurity Pharmaceuticals, INC. | $72.06 | 2023-2025 | Horizant, Horizant |
| Vanda Pharmaceuticals INC. | $70.59 | 2024-2025 | Ponvory |
| Amneal Pharmaceuticals LLC | $69.62 | 2020-2024 | Ongentys 50mg Capsules 30, Rytary |
| Supernus Pharmaceuticals, INC. | $66.12 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $60.70 | 2022-2024 | |
| Assertio Therapeutics, INC. | $56.98 | 2019 | |
| Horizon Therapeutics Plc | $49.74 | 2021-2023 | Uplizna |
| Tanabe Pharma America, INC. | $47.72 | 2024-2025 | Radicava |
| Adamas Pharmaceuticals, INC. | $47.17 | 2021 | |
| Sanofi-Aventis U.S. LLC | $43.27 | 2020 | |
| Axsome Therapeutics, INC. | $41.41 | 2025 | Symbravo |
| Banner Life Sciences, LLC | $35.42 | 2022-2024 | |
| Grt US Holding, INC. | $31.26 | 2021 | |
| Nevro Corp. | $31.17 | 2024 | Senza |
| Avanir Pharmaceuticals, INC. | $24.59 | 2019 | |
| Tg Therapeutics, INC. | $20.11 | 2023 | |
| Impel Pharmaceuticals INC. | $19.87 | 2023 | Trudhesa |
| Tonix Medicines, INC. | $19.61 | 2025 | Zembrace Symtouch |
| Globus Medical, INC. | $18.85 | 2025 | Senza |
| Impel Pharmaceuticals LLC | $18.41 | 2024 | Trudhesa |
| Kyowa Kirin, INC. | $16.19 | 2024 | Nourianz |
| Acorda Therapeutics, INC | $15.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheetal Wagle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.